| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bittersweet progress for haemophilia A
|
The Lancet Haematology,
|
|
2018
|
5 |
4 |
p. e127
|
artikel
|
| 2 |
Clinical development of voxtalisib: a pan-PI3K/mTOR inhibitor
|
Munakata, Wataru
|
|
2018
|
5 |
4 |
p. e134-e135
|
artikel
|
| 3 |
Conditioning intensity in HCT for AML: the jury is still out
|
Craddock, Charles
|
|
2018
|
5 |
4 |
p. e132-e133
|
artikel
|
| 4 |
Grb2 inhibition: a new potential targeted therapy for myeloid malignancies?
|
Thomas, Xavier
|
|
2018
|
5 |
4 |
p. e128-e129
|
artikel
|
| 5 |
Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial
|
Ohanian, Maro
|
|
2018
|
5 |
4 |
p. e136-e146
|
artikel
|
| 6 |
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trial
|
Fasslrinner, Frederick
|
|
2018
|
5 |
4 |
p. e161-e169
|
artikel
|
| 7 |
Ready-to-use food supplement, with or without arginine and citrulline, with daily chloroquine in Tanzanian children with sickle-cell disease: a double-blind, random order crossover trial
|
Cox, Sharon E
|
|
2018
|
5 |
4 |
p. e147-e160
|
artikel
|
| 8 |
Sickle-cell anaemia needs more food?
|
Hyacinth, Hyacinth I
|
|
2018
|
5 |
4 |
p. e130-e131
|
artikel
|
| 9 |
Voxtalisib (XL765) in patients with relapsed or refractory non-Hodgkin lymphoma or chronic lymphocytic leukaemia: an open-label, phase 2 trial
|
Brown, Jennifer R
|
|
2018
|
5 |
4 |
p. e170-e180
|
artikel
|
Tijdschrift beschrijving